Endoscopy 2020; 52(S 01): S249
DOI: 10.1055/s-0040-1704779
ESGE Days 2020 ePoster presentations
Thursday, April 23, 2020 09:00 – 17:00 Clinical endoscopic practice ePoster area
© Georg Thieme Verlag KG Stuttgart · New York

ANALYSIS OF PERFORMANCE MEASURES IN SMALL BOWEL CAPSULE ENDOSCOPY (SBCE)

AC Gomes
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
R Pinho
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
A Ponte
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
A Rodrigues
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
M Sousa
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
JC Silva
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
E Afecto
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
,
J Carvalho
Centro Hospitalar Vila Nova de Gaia/Espinho, Gastrenterology, Vila Nova de Gaia, Portugal
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

 
 

    Aims The European society of gastrointestinal endoscopy (ESGE) small-bowel working group identified a list of performance measures for small-bowel endoscopy with the final goal of quality improvement. The aim of this study is to analyze the performance measures for small bowel capsule endoscopy (SBCE) at a service level.

    Methods A cross-sectional analysis of SBCE performed between 01/2018-07/2019 was performed in our center. The authors evaluated the 10 performance measures (6 key and 4 minor) associated to the 5 quality domains that were proposed.

    Results The authors analyzed 241 SBCE, 55.6% female, with a mean age of 58.4 ± 18 years-old. Key performance measures: appropriate indication for SBCE according to ESGE clinical guideline in 92.5% (223/241); complete small bowel visualization in 95.9% (231/241); diagnostic yield of 47.3% (114/241); SBCEs performed within 14 days of overt bleeding episode in 78.9% (15/19); post-SBCE referral for DAE according to ESGE technical review in 24.2% (22/91); and capsule retention in 0.4% (1/241). Taking into account the minor performance measures, the following results were identified: adequate bowel preparation according to a validated cleansing scale (Brotz) in in 49.6% (114/230, excluding 11 patients with active bleeding); use of a patency capsule in patients with high risk of capsule retention in 2.6% (1/39); adequacy of SBCE reporting in 35.7% (86/241); and no SBCE reports described the reading speed.

    Conclusions In our center, only 2 key performance measures were accomplished: complete small bowel visualization (≥ 80%) and capsule retention (< 2%). Although some standards will be difficult to achieve (i.e. use of standard terminology ≥ 90% and adequate bowel preparation ≥ 95%), feedback to the staff involved in the procedure should be given to increase performance indexes and achieve the proposed standards.


    #